Table 3.
p for correlations of PASI90 and PASI100 at week 16 with characteristics of the study group (N = 145).
| Characteristics | PASI90 (118 Patients Achieved PASI90 vs. 27 Patients Who Did Not Achieve PASI90) |
PASI100 (77 Patients Achieved PASI100 vs. 68 Patients Who Did Not Achieve PASI100) |
|---|---|---|
| Age (years) 1 | 0.188 | 0.269 |
| Duration of psoriasis (years) 1 | 0.229 | 0.239 |
| Age of psoriasis onset (years) 1 | 0.734 | 0.905 |
| Weight (kg) 1 | 0.164 | 0.038 |
| BMI (kg/m2) 1 | 0.135 | 0.018 |
| BMI (normal weight vs. overweight vs. obesity) 2 | 0.376 | 0.265 |
| Gender 2 | 0.138 | 0.188 |
| Smoking status (smokers vs. non-smokers) 2 | 0.331 | 0.947 |
| Psoriasis type (I vs. II) 2 | 0.339 | 0.326 |
| PsA (yes vs. no) 2 | 0.028 | 0.160 |
| Cardiovascular disease 2 | 0.139 | 0.073 |
| Metabolic disease 2 | 0.067 | 0.152 |
| Hepatic disease 2 | 0.083 | 0.537 |
| Previous biologic therapy 2 | 0.055 | 0.265 |
1p for Student’s t test to compare numerical characteristics between patients who achieved PASI90 and patients who did not achieve PASI90. The same for PASI100. 2 p for Chi-square test to compare categorical characteristics between patients who achieved PASI90 and patients who did not achieve PASI90. The same for PASI100. Statistically significant correlations in bold.